Merck

A recent paper by Merck details the industrial synthesis of enlicitide. Just looking at the structure tells you that this must be a ferociously active molecule with huge commercial potential

Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.

U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.

Merck (NYSE:MRK) plans to present more than 100 oncology abstracts at the 2026 ASCO Annual Meeting. The company will share five year outcomes from pivotal trials of KEYTRUDA combinations in melanoma and triple negativ…

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Veeva Systems (NYSE: VEEV) will showcase the future of agentic commercial in biopharma at Veeva Commercial Summit, May 19-20 in Boston. Leaders from argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, …

The new solar farms boost Matrix’s Spanish portfolio, supporting grid reliability and long-term clean power supply.

Precigen's PAPZIMEOS wins early FDA approval with rapid insurer/physician uptake, a strong growth outlook, and improving EPS. Click to read more on PGEN stock.